Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 76 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8729088

    Toll-like receptor modulators and treatment of diseases

    The Regents of the University of California · Granted May 20, 2014 · Expires May 15, 2034

    granted

  2. US 8729115

    Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases

    CARDIOLYNX AG · Granted May 20, 2014 · Expires May 15, 2034

    granted

  3. US 8722939

    Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis

    Northwestern University · Granted May 13, 2014 · Expires May 8, 2034

    granted

  4. US 8722884

    Pyrimidine derivatives for the treatment of abnormal cell growth

    VERASTEM, INC. · Granted May 13, 2014 · Expires May 8, 2034

    granted

  5. US 8722716

    Isoxazole treatments for diabetes

    The Board of Regents of the University of Texas System · Granted May 13, 2014 · Expires May 8, 2034

    granted

  6. US 8709430

    Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  7. US 8709443

    Reovirus for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  8. US 8709417

    Combination immunotherapy for the treatment of cancer

    BOARD OF REGENTS · Granted Apr 29, 2014 · Expires Apr 24, 2034

    granted

  9. US 8703756

    Synthetic procedure and cancer treatment with cisplatin derivatives

    THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  10. US 8697079

    IgE antibodies for the treatment of cancer

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  11. US 8697628

    Methods of using AMPD2 inhibitors for the treatment of fatty liver, obesity and diabetes

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  12. US 8697375

    In vivo biofilm infection diagnosis and treatment

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  13. US 8697082

    Prevention and treatment of synucleinopathic and amyloidogenic disease

    The Regents of the University of California · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  14. US 8697076

    Antibodies selective for pathological tau dimers and prefibrillar pathological tau oligomers and their uses in treatment, diagnosis and monitoring of tauopathies

    Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  15. US 8697060

    Treatment method for relapsing-remitting multiple sclerosis

    REGENEX LLC · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  16. US 8691501

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  17. US 8685404

    Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  18. US 8686041

    Inhibition of ornithine aminotransferase for the treatment of proliferative disorders

    Northwestern University · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  19. US 8685416

    Compositions and methods for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  20. US 8685932

    Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases

    OPTION PHARMACEUTICALS, LLC · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  21. US 8679510

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  22. US 8680083

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  23. US 8680094

    1, 4-benzoxazine compounds and derivatives thereof as therapeutic drugs for the treatment of neurodegenerative conditions

    The Board of Regents of the University of Texas System · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  24. US 8680082

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.